A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma

Programmed cell death‐1 (PD‐1) and its ligand (PD‐L1) are significant mediators of immune suppression in the tumor microenvironment. We focused on the immunological impact of PD‐1/PD‐L1 signaling during tumor progression in colorectal carcinoma (CRC) and its association with resistance to neoadjuvan...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hiroyuki, Watanabe, Hirono, Hashimura, Miki, Matsumoto, Toshihide, Yokoi, Ako, Nakagawa, Mayu, Ishibashi, Yu, Ito, Takashi, Ohhigata, Kensuke, Saegusa, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353658/
https://www.ncbi.nlm.nih.gov/pubmed/35762092
http://dx.doi.org/10.1002/cjp2.285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353658/
https://www.ncbi.nlm.nih.gov/pubmed/35762092
http://dx.doi.org/10.1002/cjp2.285

Ejemplares similares